Micromedic Announces Cooperation with Axella Research LLC for the Financing and Execution of Clinical and Regulatory Activities Required for the FDA Approval of the CellDetect® Bladder Cancer Monitoring Test in the United States

 
Micromedic announced today that it has entered into a Collaboration Agreement with Axella Research LLC to advance the clinical and regulatory efforts required to commercialize the CellDetect® non-invasive test for the monitoring of bladder cancer recurrence in the United States.


Link to complete article

More News/Information
© Micromedic Technologies Ltd. site mapcontact
 
Site by Site2goal | Design Studio Michal Lehavi